I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Comparing efficacy and safety of P013, a proposed pertuzuma..:
Abolghasem Allahyari
;
Ali Ehsanpour
;
Nafiseh Ansarinejad
...
https://doi.org/10.1186/s12885-022-09895-5. , 2022
Link:
https://doi.org/10.1186/s12885-022-09895-5
RT Journal T1
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:6c0bdcd3857a489a9e4632e013af9f15&Exemplar=1&LAN=DE A1 Abolghasem Allahyari A1 Ali Ehsanpour A1 Nafiseh Ansarinejad A1 Valiollah Mehrzad A1 Behjat Kalantari A1 Jahangir Raafat A1 Mojtaba Ghadiany A1 Farhad Shahi A1 Behrooz Gharib A1 Vahid Moazed A1 Adnan Khosravi A1 Mir Hossein Mirpour A1 Sina Salari A1 Seyedmohammadreza Mortazavizadeh A1 Amirabbas Nekoyi A1 Mohsen Khani A1 Alireza Sadeghi A1 Sirus Gharib A1 Alireza Bary A1 Mehrzad Mirzania A1 Shirin Haghighat A1 Seyed Mohsen Razavi A1 Seyed Amir Hossein Emami A1 Mehran Hosseinzadeh A1 Mahdi Mirbolouk A1 Sanambar Sadighi A1 Abdolali Shahrasbi A1 Ali Esfahani A1 Masoumeh Gity A1 Nassim Anjidani A1 Hamidreza Kafi A1 Safa Najafi PB BMC YR 2022 K1 Breast Cancer K1 Pertuzumab K1 Biosimilar K1 Equivalency K1 Randomized clinical trial K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s12885-022-09895-5 LK http://dx.doi.org/https://doi.org/10.1186/s12885-022-09895-5 DO https://doi.org/10.1186/s12885-022-09895-5 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)